Table 2.
The relation between fibrosis and hormonal levels in reproductive aged and menopausal patients.
| Hormones | Fibrosis stage | Activity grade | Fibrosis stage | Activity grade | ||||
|---|---|---|---|---|---|---|---|---|
| ≤F2 | >F2 | <A2 | ≥A2 | ≤F2 | >F2 | <A2 | ≥A2 | |
| (RA) | (M) | |||||||
| N (%) | 16 (72.7%) | 6 (27.3%) | 11 (50%) | 11 (50%) | 9 (40.9%) | 13 (59.1%) | 8 (36.4%) | 14 (63.6%) |
| E2 (pg/mL) | 139.4 ± 50.72 | 68.25 ± 37.25∗ | 142.67 ± 49.31 | 97.3 ± 56.54 | 127.6 ± 44.3 | 72.3 ± 34.17∗ | 113.96 ± 52.29 | 84.04 ± 41.47 |
| TT (ng/dL) | 19.95 ± 1.55 | 22.0 ± 4.89 | 21.6 ± 3.67 | 19.4 ± 1.18 | 22.1 ± 3.67 | 38.23 ± 13.09∗ | 21.13 ± 3.18 | 37.64 ± 12.68∗ |
| PRG (ng/mL) | 1.30 ± 0.82 | 0.97 ± 0.54 | 1.5 ± 0.8 | 0.90 ± 0.51 | 0.407 ± 0.18 | 0.717 ± 0.34∗ | 0.33 ± 0.14 | 0.74 ± 0.30∗ |
∗Statistically significant difference (P < 0.05).